AZD7268 Safety and Tolerability Study

NCT01020799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: AZD7268
DRUG: Escitalopram
DRUG: Placebo capsules
DRUG: Placebo tablets

Sponsor

AstraZeneca